December 4, 2018

Eurobact 2: the new ESICM Trials Group Study

Epidemiology and determinants of outcomes of Hospital Acquired Blood Stream Infections in Intensive Care.

New ESICM Trials Group Study !

Do you have patients with a Hospital Acquired Blood Stream Infection?

Join our new ESICM Trials Group Study “Eurobact 2”, a prospective observational multinational, multicentre cohort study.
The Eurobact 1 study collected multinational data on HA-BSI in 2010 -11. A decade later, Eurobact 2 will investigate how management and outcomes of patients with severe hospital acquired infections may have changed while AMR has seen a worldwide increase.
We need you and ICUs from all over the world to support this study.

> Find more information

Comment on this news